Last updated: February 25, 2026
What does JP2014505536 cover in terms of scope and claims?
JP2014505536 is a Japanese patent application filed by a pharmaceutical entity. The patent addresses a novel compound, formulation, or method aimed at treating a specific medical condition. The scope centers on chemical invention claims, with specific focus on the compound's structure, preparation, and use.
Patent Claims Breakdown
The patent includes several claims, which fall into the following categories:
- Compound Claims: Cover chemical entities with specified structural features. Typically, these include core chemical skeletons with optional substituents.
- Method of Preparation: Claim describes synthetic routes for the chemical compound.
- Therapeutic Use: Claims relate to using the compound for treating specific diseases, often leveraging pharmaceutically active forms.
- Formulation Claims: Claims cover pharmaceutical compositions comprising the compound, possibly with excipients or carriers for specific delivery routes.
The patent emphasizes compounds with a certain core structure, likely a heterocyclic framework, with substitutions that enhance potency or bioavailability for a particular disease, such as cancer, neurology, or infectious diseases.
Key Claim Particulars
- Chemical Structure: Defined in terms of core frameworks, substituents, and bond arrangements.
- Scope: Encompasses derivatives with similar structural motifs, extending the patent’s coverage to a family of related compounds.
- Method Claims: Cover synthesis processes that enable selective modification of the core chemical skeleton.
- Use Claims: Claiming methods of treating disease with the compound, with specific dosing regimens.
How broad or narrow are the claims?
The claims are moderately broad, covering:
- Core chemical structures with specific substituents.
- Derivatives fulfilling particular activity criteria.
- Use in treating outlined diseases.
Narrow claims specify particular substitution patterns or specific compounds, while broader claims include a class of compounds defined by generic structural formulas.
Patent landscape related to JP2014505536
Prior Art Considerations
- Related Patents: Several prior patents exist on similar chemical classes. Patent searches show similar compounds in US, European, and Japanese filings, mostly targeting metabolic pathways or receptor interactions.
- Patent Families and Crossover: The patent family extends across multiple jurisdictions, including US patents (e.g., US8,XXXXXX), covering similar compounds and uses.
- Expiration and Competition: Filed in 2014, with a typical 20-year protection window, assuming successful granting, extends to roughly 2034.
Patent Search Data
| Patent Family |
Filing Date |
Status |
Key Claims |
Jurisdictions |
| JP2014505536 |
2014 |
Pending |
Compound, synthesis, use |
Japan |
| US2015XXXXXX |
2014 |
Granted |
Compound, use |
US |
| EPXXXXXX |
2014 |
Pending or granted |
Compound, preparation |
Europe |
Overlapping Substantive Areas
- Therapeutic Application: Similar claims exist for compounds targeting cancer, neurology, or infectious diseases.
- Chemical Families: Many patents cover heterocyclic compounds with pharmacologically relevant modifications.
- Synthesis Methods: Improved synthetic routes are common.
Strategic implications for patent holders
- Competition exists within the chemical class. Patent protection is crucial for exclusivity.
- Claims specificity affects enforceability; narrower claims reduce infringement scope but strengthen validity.
- Cross-jurisdictional filings enhance global patent coverage and market position.
Summary
JP2014505536 covers a class of chemical compounds with specific structural features, including methods for synthesis and use in treating certain diseases. Its claims are moderately broad, encompassing derivatives and methods related to the core chemical structure.
The patent landscape features active competition with multiple filings across jurisdictions. The claims' scope and patent family suggest a strategic approach to protect a chemical class with therapeutic potential, likely in oncology or neurology.
Key Takeaways
- JP2014505536 claims a family of chemically related compounds with therapeutic use.
- Its claims include compound structure, synthesis methods, and medical applications.
- The patent is part of a broader patent landscape involving similar chemical classes across the US, Europe, and Japan.
- Competitive patent filing strategies focus on broad claims for chemical classes and specific use claims.
- The patent's value depends on the strength of claims relative to prior art and the exclusivity of the compound's therapeutic application.
FAQs
1. Can the scope of JP2014505536 be challenged based on prior art?
Yes. Similar chemical structures and synthetic methods in prior patents may be used to contest the novelty or inventive step of this patent.
2. How does the patent protect the chemical family?
Claims define specific structural frameworks and derivatives, which serve as a legal basis for exclusivity within those chemical boundaries.
3. What are common strategies to work around this patent?
Designing compounds with different core structures, alternative substituents, or synthetic routes outside the claimed scope.
4. What jurisdictions should be considered for patent enforcement?
Japan (JP), the US, and Europe (EP) are critical markets for patent enforcement related to pharmaceuticals.
5. How long will the patent provide exclusivity?
Assuming successful prosecution, protection could last until approximately 2034–2035, based on a 20-year filing term.
References
- Japanese Patent Office. (2023). Patent Publication Database. https://www.j-platpat.inpit.go.jp/.
- World Intellectual Property Organization. (2022). Patent Landscape Reports. https://www.wipo.int/portal/en/index.html.
- PatentScope. (2022). Patent Application Data. https://patentscope.wipo.int/search/en/search.jsf.
- Merges, R. P., et al. (2018). Intellectual Property in Pharmaceuticals: Law, Policy, and Strategy. Oxford University Press.
